James Ballard, MD
Orthopaedic Surgery · Oregon City, ORNPI 1427083666
Payments from drug & device makers
Across 2,499 payments — averaging $1117.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2.8M
- Smith+Nephew$6K
- Heraeus Medical, LLC.$108
- Johnson & Johnson$103
- Dynasplint Systems Inc.$90
- Pacira Pharmaceuticals Incorporated$71
- plus $463 from 15 others
Across 1 payment — averaging $10,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Canary Medical USA LLC$10K
What the payments were for
- Royalty or licence$72,8133%
- Consulting fees$1,658,45769%
- Travel & lodging$182,0158%
- Food & beverage$30,2991%
- Education$463,02619%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 2,461 | $2,785,447 |
| Smith+Nephew | 4 | $6,032 |
| Heraeus Medical, LLC. | 4 | $108 |
| Johnson & Johnson(2 entities) | 6 | $103 |
| Dynasplint Systems Inc. | 3 | $90 |
| Pacira Pharmaceuticals Incorporated | 3 | $71 |
| Endologix LLC | 1 | $61 |
| Baudax Bio Inc. | 1 | $59 |
| Medtronic(2 entities) | 2 | $53 |
| Medacta USA, Inc. | 1 | $52 |
| Avanos Medical | 3 | $51 |
| Baxter Healthcare | 1 | $34 |
| Surgenex LLC | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Vertex | 1 | $21 |
| KCI USA, Inc. | 1 | $19 |
| Stryker | 1 | $17 |
| Orthogenrx Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $13 |
| Terumo Medical Corporation | 1 | $12 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$848,628
- Persona$682,809
- Persona Revision$211,880
- ROSA-Knee$184,116
- mymobility Platform$138,003
- Avenir$121,959
- Z1 HIP SYSTEM$84,170
- Fuzion$76,597
- G7$69,026
- Arcos$56,518
- HAMMR CURVED G7 IMPACTOR$17,325
- Oxford$16,583
- PD-Knee-New Product$11,268
- Persona IQ$10,750
- Knees Product Portfolio$7,252
- Connected Health-MyMobility$6,125
- Connected Health-None$6,081
- Patient Care$5,392
- Accelero-None$4,683
- Persona MC$3,714
How this compares
$2,792,315 in reported general payments places this provider in the 95th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 65 | $378 |
| Hydromorphone Hcl | 11 | $74 |
| Cephalexin | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oregon City
- David HubertyOregon City$37K
- Jeffrey FeinblattOregon City$37K
- Terrence SedgewickOregon City$16K
- Patrick DenardMedford$14.1M
- Steven MadeyLake Oswego$1.2M
- Daniel FitzpatrickEugene$629K
- Paul DuweliusPortland$622K
- Jonathan SalesPortland$529K
- Elizabeth LiebermanPortland$383K
- Michelle WelbornPortland$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.